While FOXO4-DIR carries substantial promise as a senolytic agent against cellular senescence, its safety profile remains largely uncharted
Endoscopic sleeve gastroplasty plus semaglutide increases weight loss owenhaskins May 21, 2021 2 min read Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research presented at Digestive Disease Week (DDW) 2021
Novo Nordisk, the manufacturer of Ozempic, does include skin reactions in their prescribing information, listing rashes and itching among possible side effects of the medication
Published September 2019
Moreover, the population eligible for GLP-1 AOMs is substantially larger than the populations diagnosed with established cardiovascular disease + obesity/overweight, MASH, or OSA
Ensure adequate protein intake (at least 0.7-1.0 grams per pound of body weight daily)